Netramark helps pharma companies identify and predict the population of candidates that would be most responsive to a drug treatment in a clinical trial. Using Netramark, pharmaceutical companies can complete the clinical drug trial process with a higher probability of success by receving insights on placebo responses and patient sub-populations.